Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
RNA Biology|October 30, 2015
HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoformsHui Li, Shuai Hou, Tian Hao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 24, 2013
Clinical implications of GRHL3 protein expression in breast cancerHuanming Xu, Caigang Liu, Zuowei Zhao, et al.
Annals of the New York Academy of Sciences|September 15, 2018
SND1 expression in breast cancer tumors is associated with poor prognosisXi Gu, Jinqi Xue, Liping Ai, et al.
Bioactive Materials|July 18, 2025
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapiesZhan Zhang, Yuanzhen Wu, Yanchen Liu, et al.
American Journal of Clinical Oncology|May 2, 2012
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodesAlatengbaolide, Dapeng Lin, Yiming Li, et al.
Cancer Science|December 24, 2009
Clinical implications for nestin protein expression in breast cancerCaigang Liu, Bo Chen, Jun Zhu, et al.
International Journal of Medical Sciences|November 9, 2020
FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosisYixiao Zhang, Xudong Zhu, Xinbo Qiao, et al.
Molecular Biology Reports|December 31, 2011
Co-expression of Oct-4 and Nestin in human breast cancersCaigang Liu, Xuezhao Cao, Yanjun Zhang, et al.
Frontiers in Oncology|April 25, 2022
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast CancerXin Tian, Lina Wu, Min Jiang, et al.
Frontiers in Oncology|May 10, 2021
Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast CancerXin Tian, Lina Wu, Min Jiang, et al.
Pageof 13